Aimeike said on an interactive platform on August 11 that up to now, the company's “simeglutide injection” project is progressing normally according to the plan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.